Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 1;17(1):6-10.
doi: 10.1002/cld.1006. eCollection 2021 Jan.

Molecular Mechanisms Linking Nonalcoholic Steatohepatitis to Cancer

Affiliations
Review

Molecular Mechanisms Linking Nonalcoholic Steatohepatitis to Cancer

Kara Wegermann et al. Clin Liver Dis (Hoboken). .

Abstract

Watch a video presentation of this article Watch an interview with the author Answer questions and earn CME.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Metabolic syndrome–initiated mechanisms key to NASH‐HCC. Excessive lipid accumulation (a key inciting event) causes oxidative stress, resulting in mitochondrial dysfunction. This leads to changes in lipid metabolism, changes in growth and development pathways, and changes in the immune system that promote HCC.
FIG 2
FIG 2
The importance of IGF signaling in NASH‐HCC. Insulin resistance and resultant hyperinsulinemia drive activation of growth pathways, including IGF‐1/AKT and mTOR. 41 IGF‐1 exerts anti‐inflammatory, antilipogenic, and antiapoptotic effects in animal models of NASH, but, paradoxically, IGF‐1R is often upregulated in HCC tissue, suggesting that the antiapoptotic effect may be driving carcinogenesis and promoting dysregulated growth. 20
FIG 3
FIG 3
Kupffer cells are activated via TREM‐1, whose activation leads to secretion of inflammatory cytokines, including TNF‐α and IL‐6. These induce alterations in NF‐κB signaling, thereby promoting dedifferentiation and proliferation of hepatocytes.

References

    1. Beste LA, Leipertz SL, Green PK, et al. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001‐2013. Gastroenterology 2015;149:1471‐1482.e5; quiz e17‐8. - PubMed
    1. Estes C, Razavi H, Loomba R, et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 2018;67:123‐133. - PMC - PubMed
    1. Kanwal F, Kramer JR, Mapakshi S, et al. Risk of hepatocellular cancer in patients with non‐alcoholic fatty liver disease. Gastroenterology 2018;155:1828‐1837.e2. - PMC - PubMed
    1. Mittal S, El‐Serag HB, Sada YH, al. Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2016;14:124‐131.e1. - PMC - PubMed
    1. Piscaglia F, Svegliati‐Baroni G, Barchetti A, et al. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study. Hepatology 2016;63:827‐838. - PubMed